Novo Nordisk - la compañia que trata la diabete...
First: Novo Nordisk India launches oral Semaglu...
Novo Nordisk A/S Sees Unusually Large Options V...
Novo Nordisk Logo Png
Is Novo Nordisk Stock a Buy After its Collapse?...
Novo Nordisk launches once-a-week diabetes drug...
Novo Nordisk hits all-time high as oral obesity...
FID prosigue su larga colaboración con Novo Nor...
Novartis' Sandoz dips on debut after lower than...
Novo Nordisk’s Global Commitment to Diabetes Ca...
China OKs Novo Nordisk's Type-2 diabetes treatm...
Novo Nordisk receives FDA approval for Wegovy™
Novo Nordisk's results are stunning - and it co...
Novo Nordisk submits diabetes pill for US approval
Signal: Novo Nordisk market cap higher than Dan...
Novo Nordisk Research Centre opens in Oxford | ...
Novo Nordisk leaps on new obesity drug data | p...
Novo Nordisk amplía sus fármacos contra la obes...
Novo Nordisk experience big profit rise due to ...
Novo Nordisk Posts Record Growth as Demand For ...
Novo Nordisk to test anti-obesity molecule in t...
Novo Nordisk
NOVO NORDISK INC.: Novo Nordisk Launches Ozempi...